A 66-year-old man is admitted with a non-ST elevation acute coronary syndrome (NSTEACS). He has ongoing chest discomfort, dynamic troponin rise and ST depression in the lateral leads. According to Australian ACS guidelines, in addition to aspirin, what is the most appropriate second antiplatelet agent for early dual antiplatelet therapy if he is planned for invasive management and has no contraindications?